Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment

Eur Respir J. 2015 Jan;45(1):260-2. doi: 10.1183/09031936.00131614. Epub 2014 Oct 30.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cohort Studies
  • Delayed-Action Preparations
  • Female
  • France
  • Humans
  • Male
  • Middle Aged
  • Muscarinic Antagonists / therapeutic use*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Quality of Life
  • Risk
  • Tiotropium Bromide / therapeutic use*

Substances

  • Delayed-Action Preparations
  • Muscarinic Antagonists
  • Tiotropium Bromide